UBS Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History
Bought
Maintained
Sold
Other funds holding CURE
SS
TCM
SF
LFG
OBWG
SG
UBS Group's CURE Position: Q2 2026 in Review
UBS Group opened a new position in Direxion Daily Healthcare Bull 3X ETF (CURE) in Q2 2026: 999 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #7123 among its holdings. This is a return to the name: UBS Group previously reported a position in CURE as recently as Q4 2025.
UBS Group first reported a position in CURE in Q1 2015 and has held it in 32 quarters since. The position peaked at $549K in Q1 2025. 19 funds tracked by Wall St. Rank hold CURE as of Q2 2026.
- UBS Group held 999 shares of Direxion Daily Healthcare Bull 3X ETF worth $112K as of Q2 2026.
- Direxion Daily Healthcare Bull 3X ETF was a new UBS Group position in Q2 2026.
- Direxion Daily Healthcare Bull 3X ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7123 holding.
- UBS Group first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2015 and has held it in 32 quarters since.
- UBS Group's Direxion Daily Healthcare Bull 3X ETF position peaked at $549K in Q1 2025.
- 19 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.